HIV-1 integrates its proviral DNA genome into the host genome, presenting barriers for virus eradication. Several new gene-editing technologies have emerged that could potentially be used to damage integrated proviral DNA. In this study, we use transcription activator-like effector nucleases (TALENs) to target a highly conserved sequence in the transactivation response element (TAR) of the HIV-1 proviral DNA. We demonstrated that TALENs cleave a DNA template with the HIV-1 proviral target site in vitro. A GFP reporter, under control of HIV-1 TAR, was efficiently inactivated by mutations introduced by transfection of TALEN plasmids. When infected cells containing the full-length integrated HIV-1 proviral DNA were transfected with TALENs, the...
Tese de doutoramento, Farmácia (Biotecnologia Farmacêutica), Universidade de Lisboa, Faculdade de Fa...
Novel therapeutic strategies aiming at the permanent inactivation of the HIV-1 reservoir in infected...
Novel therapeutic strategies aiming at the permanent inactivation of the HIV-1 reservoir in infected...
DNA-editing technology has made it possible to rewrite genetic information in living cells. Human im...
<div><p>DNA-editing technology has made it possible to rewrite genetic information in living cells. ...
Background: Despite potent antiretroviral drugs, HIV-1 infection cannot be eliminated and patients m...
<p>A. Schematic diagram of the complete HIV-1 proviral DNA to be targeted by the HT-TALEN pair or th...
AbstractThe major obstacle to cure infections with human immunodeficiency virus (HIV-1) is integrate...
Despite the great success of highly active antiretroviral therapy (HAART) in ameliorating the course...
<p>(A) LTR-driven GFP expression after TF with CRISPR/Cas9 or TALENs expressing plasmid DNA. Jurkat ...
Abstract Current treatment for HIV-1 largely relies on chemotherapy through the administration of an...
Highly active anti-retroviral therapy (HAART) cannot clear infected cells harboring HIV-1 proviral D...
The TAR element is a viral regulatory element extending from 11 to 160 in the human immunodeficiency...
Current antiretroviral drugs can efficiently block HIV replication and prevent transmission, but do ...
Homozygosity for a natural deletion variant of the HIV-coreceptor molecule CCR5, CCR532, confers res...
Tese de doutoramento, Farmácia (Biotecnologia Farmacêutica), Universidade de Lisboa, Faculdade de Fa...
Novel therapeutic strategies aiming at the permanent inactivation of the HIV-1 reservoir in infected...
Novel therapeutic strategies aiming at the permanent inactivation of the HIV-1 reservoir in infected...
DNA-editing technology has made it possible to rewrite genetic information in living cells. Human im...
<div><p>DNA-editing technology has made it possible to rewrite genetic information in living cells. ...
Background: Despite potent antiretroviral drugs, HIV-1 infection cannot be eliminated and patients m...
<p>A. Schematic diagram of the complete HIV-1 proviral DNA to be targeted by the HT-TALEN pair or th...
AbstractThe major obstacle to cure infections with human immunodeficiency virus (HIV-1) is integrate...
Despite the great success of highly active antiretroviral therapy (HAART) in ameliorating the course...
<p>(A) LTR-driven GFP expression after TF with CRISPR/Cas9 or TALENs expressing plasmid DNA. Jurkat ...
Abstract Current treatment for HIV-1 largely relies on chemotherapy through the administration of an...
Highly active anti-retroviral therapy (HAART) cannot clear infected cells harboring HIV-1 proviral D...
The TAR element is a viral regulatory element extending from 11 to 160 in the human immunodeficiency...
Current antiretroviral drugs can efficiently block HIV replication and prevent transmission, but do ...
Homozygosity for a natural deletion variant of the HIV-coreceptor molecule CCR5, CCR532, confers res...
Tese de doutoramento, Farmácia (Biotecnologia Farmacêutica), Universidade de Lisboa, Faculdade de Fa...
Novel therapeutic strategies aiming at the permanent inactivation of the HIV-1 reservoir in infected...
Novel therapeutic strategies aiming at the permanent inactivation of the HIV-1 reservoir in infected...